References
- Abdelmohsen UR, Bayer K, Hentschel U. 2014. Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat Prod Rep. 31(3):381–399.
- Ahmed SA, Khalifa SI, Hamann MT. 2008. Antiepileptic ceramides from the Red Sea sponge Negombata corticata. J Nat Prod. 71(4):513–515.
- Bayarkhangai B, Noureldin S, Yu L, Zhao N, Gu Y, Xu H, Guo C. 2018. A comprehensive and perspective view of oncoprotein SET in cancer. Cancer Med. 7(7):3084–3094.
- Bergmann W, Burke DC. 1955. Contributions to the study of marine products. XXXIX. The nucleosides of sponges. III. 1 Spongothymidine and spongouridine2. J Org Chem. 20(11):1501–1507.
- Costantino V, Fattorusso E, Imperatore C, Mangoni A, Teta R. 2009. Amphiceramide A and B, novel glycosphingolipids from the marine sponge Amphimedon compressa. Eur J Org Chem. 2009(13):2112–2119.
- Eltahawy NA, Ibrahim AK, Gomaa MS, Zaitone SA, Radwan MM, Hassanean HA, ElSohly MA, Ahmed SA. 2019. Anxiolytic and anticonvulsant activity followed by molecular docking study of ceramides from the Red Sea sponge Negombata sp [journal article]. Med Chem Res. 28(11):1818–1827.
- Emura C, Higuchi R, Miyamoto T, Van Soest RW. 2005. Amphimelibiosides A-F, six new ceramide dihexosides isolated from a Japanese marine sponge Amphimedon sp. J Org Chem. 70(8):3031–3038.
- Hirano K, Kubota T, Tsuda M, Mikami Y, Kobayashi J. 2000. Pyrinodemins B-D, potent cytotoxic bis-pyridine alkaloids from marine sponge amphimedon sp. Chem Pharm Bull. 48(7):974–977.
- Khazir J, Mir BA, Pilcher LA, Riley DL, Cowan DA. 2014. Anticancer agents from diverse natural sources. Nat Prod Commun. 9(11):1655–1669.
- Molinski TF, Dalisay DS, Lievens SL, Saludes JP. 2009. Drug development from marine natural products. Nat Rev Drug Discov. 8(1):69–85.
- Reyes F, Martín R, Fernandez R. 2006. Granulatamides A and B, cytotoxic tryptamine derivatives from the soft coral Eunicella granulata. J Nat Prod. 69(4):668–670.
- Robertson V. 2013. Bacterial diversity of the octocoral Pseudopterogorgia elisabethae via culture-dependent and culture-independent methods and screening of selected bacteria for antimicrobial activity. Canada: University of Prince Edward Island.
- Schwartsmann G, da Rocha AB, Berlinck RG, Jimeno J. 2001. Marine organisms as a source of new anticancer agents. Lancet Oncol. 2(4):221–225.
- Shady NH, Fouad MA, Ahmed S, Pimentel-Elardo SM, Nodwell JR, Kamel MS, Abdelmohsen UR. 2018. A new antitrypanosomal alkaloid from the Red Sea marine sponge Hyrtios sp. J Antibiot. 71(12):1036–1039.
- Ter Haar E, Kowalski RJ, Hamel E, Lin CM, Longley RE, Gunasekera SP, Rosenkranz HS, Day BW. 1996. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry. 35(1):243–250.
- Tewari D, Rawat P, Singh PK. 2019. Adverse drug reactions of anticancer drugs derived from natural sources. Food Chem Toxicol. 123:522–535.
- Tsuda M, Hirano K, Kubota T, Kobayashi J. 1999. Pyrinodemin A, a cytotoxic pyridine alkaloid with an isoxazolidine moiety from sponge Amphimedon sp. Tetrahedron Lett. 40(26):4819–4820.
- Tsukamoto S, Takahashi M, Matsunaga S, Fusetani N, van Soest RWM. 2000. Hachijodines A-G: seven new cytotoxic 3-alkylpyridine alkaloids from two marine sponges of the genera Xestospongia and amphimedon. J Nat Prod. 63(5):682–684.
- Wang W-S, Tzeng C-H, Chiou T-J, Liu J-H, Fan S, Chen P-M. 1996. High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma. Zhonghua yi xue za zhi = Chinese medical journal. Free China ed. 57(2):100–105.